RS64694B1 - Kombinacija fiksne doze memantina i donepezila sa trenutnim oslobađanjem - Google Patents

Kombinacija fiksne doze memantina i donepezila sa trenutnim oslobađanjem

Info

Publication number
RS64694B1
RS64694B1 RS20230893A RSP20230893A RS64694B1 RS 64694 B1 RS64694 B1 RS 64694B1 RS 20230893 A RS20230893 A RS 20230893A RS P20230893 A RSP20230893 A RS P20230893A RS 64694 B1 RS64694 B1 RS 64694B1
Authority
RS
Serbia
Prior art keywords
memantine
composition
donepezil
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
RS20230893A
Other languages
English (en)
Serbian (sr)
Inventor
Machuco Estevens Maria Catarina Oliveira
Marques Da Costa Ricardo Manuel Silva
Serra João Pedro Silva
Filipe Augusto Eugénio Pardal
Original Assignee
Tecnimede Sociedade Tecnico Medicinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal Sa filed Critical Tecnimede Sociedade Tecnico Medicinal Sa
Priority claimed from PCT/IB2020/055137 external-priority patent/WO2020240505A1/fr
Publication of RS64694B1 publication Critical patent/RS64694B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RS20230893A 2019-05-31 2020-05-29 Kombinacija fiksne doze memantina i donepezila sa trenutnim oslobađanjem RS64694B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT2019115557 2019-05-31
PCT/IB2020/055137 WO2020240505A1 (fr) 2019-05-31 2020-05-29 Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil
EP20732664.6A EP3843702B1 (fr) 2019-05-31 2020-05-29 Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil

Publications (1)

Publication Number Publication Date
RS64694B1 true RS64694B1 (sr) 2023-11-30

Family

ID=88650785

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20230893A RS64694B1 (sr) 2019-05-31 2020-05-29 Kombinacija fiksne doze memantina i donepezila sa trenutnim oslobađanjem

Country Status (7)

Country Link
ES (1) ES2960207T3 (fr)
HU (1) HUE063622T2 (fr)
LT (1) LT3843702T (fr)
MA (1) MA53513B1 (fr)
PL (1) PL3843702T4 (fr)
RS (1) RS64694B1 (fr)
SM (1) SMT202300336T1 (fr)

Also Published As

Publication number Publication date
MA53513B1 (fr) 2023-10-31
HUE063622T2 (hu) 2024-01-28
SMT202300336T1 (it) 2023-11-13
PL3843702T3 (pl) 2024-04-08
LT3843702T (lt) 2023-11-10
ES2960207T3 (es) 2024-03-01
PL3843702T4 (pl) 2024-04-08
MA53513A (fr) 2021-09-08

Similar Documents

Publication Publication Date Title
EP1341527B1 (fr) Preparation pharmaceutique comprenant un principe actif disperse sur une matrice
US6660382B2 (en) Process for manufacturing coated granules with masked taste and immediate release of the active principle
US9089485B2 (en) Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
US20080008752A1 (en) Pharmaceutical compositions of memantine
EP1738754B1 (fr) Preparation pharmaceutique solide
JP2011526622A (ja) クエチアピンを含む徐放性医薬組成物
US9814711B2 (en) Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation
US20190046449A1 (en) A unique high-shear granulation process for improved bioavailability of rivaroxaban
TWI418370B (zh) 溶出安定性製劑
US20140343076A1 (en) Pharmaceutical compositions of lurasidone
JP2016512845A (ja) ソバプレビル錠剤
KR101938872B1 (ko) 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
RS64694B1 (sr) Kombinacija fiksne doze memantina i donepezila sa trenutnim oslobađanjem
WO2006035313A1 (fr) Formes posologiques unitaires solides d'un agoniste de 5-ht1
EP3843702B1 (fr) Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil
WO2018101681A1 (fr) Comprimé composite oral comprenant de l'ézétimibe et de la rosuvastatine
WO2020122244A1 (fr) Comprimé, et procédé de fabrication de celui-ci
RU2829142C1 (ru) Фармацевтическая пероральная лекарственная форма q203
US20250134841A1 (en) Pharmaceutical composition of bempedoic acid
EA051960B1 (ru) Фармацевтическая композиция бемпедоевой кислоты
EP4491175A1 (fr) Composition orale solide de ruxolitinib
JP2009538905A (ja) 感湿性薬物を含んで成る安定性製剤及びその製造方法
WO2022029798A1 (fr) Compositions pharmaceutiques comprenant du ribociclib
HK40011903A (en) Pharmaceutical composition for preventing or treating dementia and cognitive dysfunction, containing donepezil or pharmaceutically acceptable salt thereof and memantine or pharmaceutically acceptable salt thereof, and preparation method therefor
HK1112841A (en) Pharmaceutical compositions of memantine